We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
CareDx
CDNA
$1.85B
| $865K | ﹤0.01% |
55,711
-211,002
| -79% | -$2.55M |
|
1727
Phinia Inc
PHIN
$2.98B
| $864K | ﹤0.01% |
21,958
-60,641
| -73% | -$2.5M |
|
1728
Group 1 Automotive
GPI
$4.17B
| $862K | ﹤0.01% |
2,900
-993
| -26% | -$294K |
|
1729
CVB Financial
CVBF
$4.02B
| $856K | ﹤0.01% |
+49,635
| New | +$827K |
|
1730
National Beverage
FIZZ
$3.05B
| $854K | ﹤0.01% |
16,668
+8,868
| +114% | +$415K |
|
|
BRDG
1731
DELISTED
Bridge Investment Group
BRDG
| $852K | ﹤0.01% |
114,769
+20,726
| +22% | +$148K |
|
1732
Henry Schein
HSIC
$9.76B
| $851K | ﹤0.01% |
+13,282
| New | +$935K |
|
1733
Phreesia
PHR
$671M
| $848K | ﹤0.01% |
40,010
-113,068
| -74% | -$2.45M |
|
1734
Chegg
CHGG
$121M
| $848K | ﹤0.01% |
268,365
+236,565
| +744% | +$1.18M |
|
1735
Tiptree Inc
TIPT
$678M
| $846K | ﹤0.01% |
51,312
+27,335
| +114% | +$457K |
|
1736
HealthEquity
HQY
$8.46B
| $845K | ﹤0.01% |
9,800
-32,832
| -77% | -$2.65M |
|
1737
GoodRx Holdings
GDRX
$1.06B
| $843K | ﹤0.01% |
+108,100
| New | +$801K |
|
1738
Clearway Energy Class C
CWEN
$4.9B
| $839K | ﹤0.01% |
33,971
-3,173
| -9% | -$80.2K |
|
1739
Forestar Group
FOR
$1.5B
| $835K | ﹤0.01% |
+26,098
| New | +$883K |
|
1740
iShares US Medical Devices ETF
IHI
$3.14B
| $835K | ﹤0.01% |
14,896
-334,539
| -96% | -$18.7M |
|
1741
Upwork
UPWK
$1.21B
| $834K | ﹤0.01% |
+77,584
| New | +$880K |
|
1742
Inseego
INSG
$111M
| $833K | ﹤0.01% |
+78,138
| New | +$455K |
|
1743
Lindsay Corp
LNN
$1.17B
| $833K | ﹤0.01% |
6,775
+3,488
| +106% | +$406K |
|
1744
IonQ
IONQ
$12.6B
| $831K | ﹤0.01% |
118,236
-216,873
| -65% | -$1.78M |
|
1745
Geospace Technologies
GEOS
$88.4M
| $829K | ﹤0.01% |
92,267
-2,400
| -3% | -$27K |
|
|
SYRS
1746
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $828K | ﹤0.01% |
160,390
+806
| +0.5% | +$4.24K |
|
1747
iShares MSCI Brazil ETF
EWZ
$9.13B
| $824K | ﹤0.01% |
+30,162
| New | +$915K |
|
1748
American Public Education
APEI
$917M
| $815K | ﹤0.01% |
46,354
-88,582
| -66% | -$1.39M |
|
|
VISN
1749
Vistance Networks Inc
VISN
$2.67B
| $814K | ﹤0.01% |
661,777
+481,947
| +268% | +$573K |
|
1750
BWX Technologies
BWXT
$15.5B
| $814K | ﹤0.01% |
+8,564
| New | +$794K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.